Logotype for Edgewise Therapeutics Inc

Edgewise Therapeutics (EWTX) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Edgewise Therapeutics Inc

Proxy filing summary

23 Apr, 2026

Voting matters and shareholder proposals

  • Election of three directors to serve until the 2029 Annual Meeting: Laura Brege, Badreddin Edris, Ph.D., and Jonathan Root, M.D.

  • Ratification of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.

  • Advisory vote on the compensation of named executive officers.

  • Proxies may vote on other business that may properly come before the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends voting in favor of all director nominees and proposals.

  • Annual meeting scheduled for June 4, 2026, at company headquarters in Boulder, Colorado.

Executive compensation and say-on-pay

  • Advisory vote to approve the compensation of named executive officers is included as a voting item.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more